CarlosEduardoMillaMD
Pediatric Pulmonology • Palo Alto, CAAssociate Professor, Pediatrics - Pulmonary Medicine, Stanford University Medical Center
Dr. Milla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-498-7200- Is this information wrong?
Education & Training
Cayetano Heredia UniversityClass of 1986, MD
Certifications & Licensure
CA State Medical License 2007 - 2024
MN State Medical License 1992 - 2007- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele Start of enrollment: 2019 Nov 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsClinical and functional spectrum of RAC2-related immunodeficiency.Ágnes Donkó, Svetlana O Sharapova, Juraj Kabat, Sundar Ganesan, Fabian H Hauck, Jenna R E Bergerson, Louis Marois, Jordan Abbott, Despina Moshous, Kelli W Williams, Ni...> ;Blood. 2024 Apr 11
- Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding.Qingquan Chen, Pam Cai, Tony Hong Wei Chang, Michael J Kratochvil, Aditi Gupta, Aviv Hargil, Patrick R Secor, Josefine Eilsø Nielsen, Annelise E Barron, Sarah C Heilsh...> ;Biorxiv. 2024 Mar 10
- The Inovirus Pf4 Triggers Antiviral Responses and Disrupts the Proliferation of Airway Basal Epithelial Cells.Popescu, M., Haddock, N., Rojas-Hernandez, L., Kaber, G., Hargil, A., Burgener, E., Bollyky, P., Milla, C.> ;Viruses. 2024 Jan 22
- Join now to see all
Press Mentions
- Double CF Combination Safe, Effective in 1- to 2-Year-OldsDecember 30th, 2022
- Scientists Decipher the Danger of Gummy Phlegm in Severe COVID-19June 24th, 2022
- Stanford Scientists Decipher the Danger of Gummy Phlegm in Severe COVID-19June 22nd, 2022
- Join now to see all
Grant Support
- Inhaled Sodium Pyruvate For The Treatment Of Cystic Fibrosis A Phase I, DoubleNational Center For Research Resources2007
- A Double-Blind, Randomized, Placebo-Controlled, 28-Day Study Of Denufosol TetrasNational Center For Research Resources2007
- A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial WithNational Center For Research Resources2006–2007
- Assessment Of Induced Sputum As A Tool To Evaluate Anti-Inflammatory Agents In CNational Center For Research Resources2006
- A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study Of DNational Center For Research Resources2006
- Multi-Center, Double-Blind, Placebo-Controlled, Phase II Study Of Aerosolized TGNational Center For Research Resources2004–2006
- A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study Of InNational Center For Research Resources2005
- Safety And Tolerability Study Of Aztreonam For Inhalation In Cystic FibrosisNational Center For Research Resources2004
Hospital Affiliations
Lucile Packard Children's Hospital StanfordPalo Alto, California
Valley Children's HealthcareMadera, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
